Aqr Capital Management LLC Akero Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $66,777 - $295,336	5,868 Added 53.84%	16,767 $391,000
Q3 2023 Nov 14, 2023	SELL	$41.19 - $52.25 $293,890 - $372,803	-7,135 Reduced 39.56%	10,899 $551,000
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $441,278 - $680,398	-11,962 Reduced 39.88%	18,034 $842,000
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $607,985 - $819,565	16,313 Added 119.22%	29,996 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $457,559 - $749,828	13,683 New	13,683 $749,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.36B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.